Disc Medicine, Inc. (IRON) — Stock Score Summary

Disc Medicine, Inc. (IRON) has a MoatMap StockRank of 24/100 based on Quality (40/100), Value (36/100), and Momentum (33/100) factor scores. The current signal is SELL. Disc Medicine is a clinical-stage biopharmaceutical company. It has no approved products or commercial revenues, making it highly speculative and completely outside our mandate of high-ROIC, established compounders.

Disc Medicine is a clinical-stage biopharmaceutical company focused on discovering and developing novel treatments for patients with serious hematologic diseases. It targets rare blood disorders with unmet medical needs, leveraging a deep understanding of hematopoiesis and iron metabolism pathways. The company's pipeline includes multiple clinical-stage assets, aiming to be a leader in specific therapeutic areas like myelodysplastic syndromes and porphyrias.

Key Financial Metrics

Price$68.34
Market Cap$2.7B
P/E (Forward)-9.48
Price/Book3.94
Return on Equity-35.8%
Return on Invested Capital-27.0%
Debt/Equity4.51
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-121M

Disc Medicine, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Disc Medicine, Inc.’s (IRON) StockRank?
MoatMap’s StockRank for Disc Medicine, Inc. (IRON) is 24/100, with a Sell signal. It is a composite of Quality (40), Value (36), and Momentum (33) factor ranks across MoatMap’s 19,000+ stock universe.
Does Disc Medicine, Inc. have an economic moat?
Disc Medicine, Inc. (IRON) has a Quality factor score of 40/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Disc Medicine, Inc. a buy, hold, or sell?
MoatMap’s current signal for Disc Medicine, Inc. (IRON) is Sell, based on a StockRank of 24/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Disc Medicine, Inc. in?
Disc Medicine, Inc. (IRON) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksIRON deep dive reportAI ChampionsHow we score stocksSense-check another stock